Snowden Capital Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
7,120
-9
| -0.1% | -$1.94K | 0.04% | 396 |
|
|
2026
Q1 | $1.43M | Buy |
7,129
+468
| +7% | +$96.8K | 0.04% | 418 |
|
|
2025
Q4 | $1.38M | Sell |
6,661
-479
| -7% | -$95.7K | 0.04% | 424 |
|
|
2025
Q3 | $1.28M | Buy |
7,140
+897
| +14% | +$153K | 0.04% | 448 |
|
|
2025
Q2 | $1.01M | Sell |
6,243
-497
| -7% | -$79.2K | 0.03% | 514 |
|
|
2025
Q1 | $1.15M | Buy |
6,740
+38
| +0.6% | +$6.6K | 0.04% | 460 |
|
|
2024
Q4 | $1.11M | Buy |
6,702
+5,059
| +308% | +$864K | 0.03% | 480 |
|
|
2024
Q3 | $282K | Sell |
1,643
-680
| -29% | -$113K | 0.01% | 1023 |
|
|
2024
Q2 | $358K | Sell |
2,323
-488
| -17% | -$73.2K | 0.01% | 897 |
|
|
2024
Q1 | $432K | Buy |
2,811
+862
| +44% | +$131K | 0.01% | 825 |
|
|
2023
Q4 | $308K | Hold |
1,949
| – | – | 0.01% | 896 |
|
|
2023
Q3 | $285K | Sell |
1,949
-335
| -15% | -$51K | 0.01% | 882 |
|
|
2023
Q2 | $350K | Buy |
2,284
+6
| +0.3% | +$936 | 0.01% | 891 |
|
|
2023
Q1 | $353K | Sell |
2,278
-121
| -5% | -$19K | 0.01% | 885 |
|
|
2022
Q4 | $370K | Sell |
2,399
-95
| -4% | -$14K | 0.02% | 847 |
|
|
2022
Q3 | $329K | Sell |
2,494
-70
| -3% | -$9.82K | 0.01% | 862 |
|
|
2022
Q2 | $347K | Buy |
2,564
+149
| +6% | +$20.5K | 0.02% | 802 |
|
|
2022
Q1 | $360K | Buy |
2,415
+140
| +6% | +$20.7K | 0.01% | 746 |
|
|
2021
Q4 | $368K | Sell |
2,275
-1,813
| -44% | -$293K | 0.02% | 519 |
|
|
2021
Q3 | $679K | Buy |
4,088
+66
| +2% | +$11.3K | 0.03% | 455 |
|
|
2021
Q2 | $694K | Sell |
4,022
-538
| -12% | -$88.9K | 0.03% | 456 |
|
|
2021
Q1 | $732K | Sell |
4,560
-1,187
| -21% | -$203K | 0.04% | 403 |
|
|
2020
Q4 | $965K | Sell |
5,747
-424
| -7% | -$68.8K | 0.06% | 310 |
|
|
2020
Q3 | $970K | Buy |
6,171
+5
| +0.1% | +$817 | 0.08% | 274 |
|
|
2020
Q2 | $1.03M | Sell |
6,166
-294
| -5% | -$46.1K | 0.09% | 258 |
|
|
2020
Q1 | $847K | Buy |
6,460
+244
| +4% | +$34.8K | 0.09% | 264 |
|
|
2019
Q4 | $924K | Buy |
6,216
+2,234
| +56% | +$307K | 0.08% | 282 |
|
|
2019
Q3 | $493K | Buy |
3,982
+79
| +2% | +$10.5K | 0.05% | 343 |
|
|
2019
Q2 | $550K | Buy |
3,903
+680
| +21% | +$93.8K | 0.06% | 322 |
|
|
2019
Q1 | $486K | Buy |
3,223
+319
| +11% | +$45.9K | 0.05% | 326 |
|
|
2018
Q4 | $361K | Buy |
2,904
+905
| +45% | +$124K | 0.05% | 348 |
|
|
2018
Q3 | $317K | Buy |
1,999
+35
| +2% | +$5.3K | 0.04% | 386 |
|
|
2018
Q2 | $275K | Buy |
1,964
+320
| +19% | +$43.9K | 0.04% | 380 |
|
|
2018
Q1 | $218K | Buy |
+1,644
| New | +$224K | 0.03% | 355 |
|
Other funds holding FBT
BFG
Snowden Capital Advisors's FBT Position: Q2 2026 in Review
Snowden Capital Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.13% in Q2 2026, selling an estimated $1.94K and leaving 7,120 shares worth $1.76M. The position accounts for 0.04% of the portfolio, ranked #396.
Snowden Capital Advisors first reported a position in FBT in Q1 2018 and has held it in 34 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Snowden Capital Advisors held 7,120 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.76M as of Q2 2026.
- Snowden Capital Advisors sold 9 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.94K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Snowden Capital Advisors's portfolio in Q2 2026, its #396 holding.
- Snowden Capital Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and has held it in 34 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.